GDF-15 as a diagnostic marker for predicting clinical outcomes of treatment with immune checkpoint blockers

摘要

The present invention, for example, a method for predicting the probability of response of a human cancer patient to immune checkpoint blocker treatment with anti-PD-1 and predicting the probability of survival of a human cancer patient after immune checkpoint blocker treatment And devices and kits that can be used in these methods.